Photos can pop when one area is in sharp focus and the other blurry, providing the impression of depth in a two-dimensional image that matches how our eyes focus on objects, even though we don’t ...

Daraxonrasib is poised to become the new standard of care for previously treated metastatic pancreatic cancer after detailed results from a Phase III clinical trial were released at the American ...

This year’s meeting of the American Society of Clinical Oncology is abuzz with talk of RAS inhibitors, largely driven by Revolution Medicines’ barnburner pancreatic cancer data drop earlier this year.

The Higher Education Commission (HEC) has issued comprehensive guidelines for the appointment, workload, remuneration and performance evaluation of visiting faculty members at public and private ...

RAS mutations are among the most common drivers in cancer, particularly in pancreatic, colorectal, and lung tumors. Despite that, directly targeting RAS proteins proved extremely difficult for years, ...

Laurence Wall is a Contributor at DualShockers who has been writing professionally since 2022 and covering games since 2023. He primarily writes guides and lists, with a focus on indie games, RPGs, ...

Nahda Nabiilah is a writer and editor from Indonesia. She has always loved writing and playing games, so one day she decided to combine the two. Most of the time, writing gaming guides is a blast for ...

Getting a depth module in Subnautica 2 increases your tadpole submarine's depth resistance and lets you explore further without having to worry about finding oxygen spots. However, you'll reach the ...

The targeted RAS inhibitor daraxonrasib was found to be safe and showed signs of efficacy in patients with previously treated RAS-mutant metastatic pancreatic cancer, according to a Phase I/II ...

Still looking? See more results on Wirecutter. We independently review everything we recommend. When you buy through our links, we may earn a commission. Learn more› By Rachel Wharton Rachel Wharton ...

Skincare brand RAS Luxury Skincare has raised $7.5 million in a Series B funding round led by Dabur Ventures, with participation from Unilever Ventures. The Raipur-based company had previously raised ...